产品说明书

Dabigatran etexilate mesylate

Print
Chemical Structure| 872728-81-9 同义名 : BIBR 1048MS;Dabigatran etexilate methanesulfonate;Dabigatran etexilate (mesylate);Pradaxa
CAS号 : 872728-81-9
货号 : A412174
分子式 : C35H45N7O8S
纯度 : 98%
分子量 : 723.839
MDL号 : MFCD25424070
存储条件:

粉末 Inert atmosphere,2-8°C

液体 -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 25 mg/mL(34.54 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方:
生物活性
描述 Dabigatran etexilate mesylate is the orally active prodrug of dabigatran, a reversible and selective, direct thrombin inhibitor (DTI) with Ki value of 4.5 nM.
临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT02171572 Healthy Phase 1 Completed - -
NCT02904499 - Completed - France ... 展开 >> University Hospital of Reunion Island Saint Denis, Reunion Island, France, 97400 收起 <<
NCT02921126 - Completed - Italy ... 展开 >> Local Institution Ravenna, Italy, 48121 收起 <<
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

1.38mL

0.28mL

0.14mL

6.91mL

1.38mL

0.69mL

13.82mL

2.76mL

1.38mL

参考文献

[1]Kansal AR, Sorensen SV, et al. Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation. Heart. 2012 Apr;98(7):573-8.

[2]Wienen W, Stassen JM, et al. In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate. Thromb Haemost. 2007 Jul;98(1):155-62.